Short Term Group Therapy for Anxiety Disorder

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00229281
First received: September 28, 2005
Last updated: December 18, 2007
Last verified: December 2007
  Purpose

Assessing Anxiety in patient suffering from anxiety disorders (NOT OCD or PTSD)before and after group therapy


Condition Intervention
Anxiety Disorder
Behavioral: Group therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 30
Study Start Date: February 2004
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Anxiety disorder (other than OCD or PTSD)
  • Eligibility to participate in group therapy

Exclusion Criteria:

  • OCD
  • PTSD
  • Suicidal thoughts
  • Psychotic state
  • Severe hostile personality disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00229281

Locations
Israel
Chaim Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229281     History of Changes
Other Study ID Numbers: SHEBA-05-3680-JZ-CTIL
Study First Received: September 28, 2005
Last Updated: December 18, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Anxiety Disorders
Disease
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on September 22, 2014